O	0	6	Effect
O	7	9	of
B-intervention	10	17	Patient
I-intervention	18	28	Navigation
O	29	31	on
O	32	38	Breast
O	39	45	Cancer
O	46	55	Screening
O	56	61	Among
B-ethinicity	62	69	African
I-ethinicity	70	78	American
O	79	87	Medicare
O	88	101	Beneficiaries
O	101	102	:
O	103	104	A
O	105	115	Randomized
O	116	126	Controlled
O	127	132	Trial
O	132	133	.

O	134	139	There
O	140	142	is
O	143	150	growing
O	151	159	evidence
O	160	164	that
O	165	172	patient
O	173	183	navigation
O	184	192	improves
O	193	199	breast
O	200	206	cancer
O	207	216	screening
O	217	222	rates
O	222	223	;
O	224	231	however
O	231	232	,
O	233	238	there
O	239	242	are
O	243	250	limited
O	251	259	efficacy
O	260	267	studies
O	268	270	of
O	271	274	its
O	275	281	effect
O	282	287	among
O	288	295	African
O	296	304	American
O	305	310	older
O	311	316	adult
O	317	322	women
O	322	323	.

O	324	326	To
O	327	335	evaluate
O	336	339	the
O	340	346	effect
O	347	349	of
O	350	357	patient
O	358	368	navigation
O	369	371	on
O	372	381	screening
O	382	393	mammography
O	394	399	among
O	400	407	African
O	408	416	American
O	417	423	female
O	424	432	Medicare
O	433	446	beneficiaries
O	447	449	in
O	450	459	Baltimore
O	459	460	,
O	461	463	MD
O	463	464	.

O	465	468	The
O	469	475	Cancer
O	476	486	Prevention
O	487	490	and
O	491	500	Treatment
O	501	514	Demonstration
O	515	516	(
O	516	520	CPTD
O	520	521	)
O	521	522	,
O	523	524	a
O	525	530	multi
O	530	531	-
O	531	535	site
O	536	541	study
O	541	542	,
O	543	546	was
O	547	548	a
O	549	559	randomized
O	560	570	controlled
O	571	576	trial
O	577	586	conducted
O	587	591	from
O	592	597	April
O	598	602	2006
O	603	610	through
O	611	619	December
O	620	624	2010
O	624	625	.

O	626	635	Community
O	635	636	-
O	636	641	based
O	642	645	and
O	646	654	clinical
O	655	662	setting
O	662	663	.

O	664	667	The
O	668	672	CPTD
O	673	682	Screening
O	683	688	Trial
O	689	697	enrolled
B-total-participants	698	702	1905
B-eligibility	703	712	community
I-eligibility	712	713	-
I-eligibility	713	721	dwelling
I-eligibility	722	729	African
I-eligibility	730	738	American
I-eligibility	739	745	female
I-eligibility	746	754	Medicare
I-eligibility	755	768	beneficiaries
O	769	772	who
O	773	777	were
B-age	778	779	â‰¥
I-age	779	781	65
I-age	782	787	years
O	788	790	of
O	791	794	age
O	795	798	and
O	799	806	resided
O	807	809	in
O	810	819	Baltimore
O	819	820	,
O	821	823	MD
O	823	824	.

O	825	837	Participants
O	838	842	were
O	843	852	recruited
O	853	857	from
O	858	864	health
O	865	872	clinics
O	872	873	,
O	874	883	community
O	884	891	centers
O	891	892	,
O	893	899	health
O	900	905	fairs
O	905	906	,
O	907	915	mailings
O	916	921	using
O	922	930	Medicare
O	931	938	rosters
O	938	939	,
O	940	943	and
O	944	949	phone
O	950	955	calls
O	955	956	.

O	957	969	Participants
O	970	974	were
O	975	985	randomized
O	986	988	to
O	989	995	either
O	995	996	:
O	997	1004	printed
O	1005	1016	educational
O	1017	1026	materials
O	1027	1029	on
B-control	1030	1036	cancer
I-control	1037	1046	screening
I-control	1047	1048	(
I-control	1048	1055	control
I-control	1056	1061	group
I-control	1061	1062	)
O	1063	1065	or
O	1066	1073	printed
O	1074	1085	educational
O	1086	1095	materials
O	1096	1097	+
O	1098	1105	patient
O	1106	1116	navigation
O	1117	1125	services
O	1126	1134	designed
O	1135	1137	to
O	1138	1142	help
O	1143	1155	participants
O	1156	1164	overcome
O	1165	1173	barriers
O	1174	1176	to
O	1177	1183	cancer
O	1184	1193	screening
O	1194	1195	(
O	1195	1207	intervention
O	1208	1213	group
O	1213	1214	)
O	1214	1215	.

O	1216	1220	Self
O	1220	1221	-
O	1221	1229	reported
O	1230	1237	receipt
O	1238	1240	of
O	1241	1252	mammography
O	1253	1262	screening
O	1263	1269	within
O	1270	1271	2
O	1272	1277	years
O	1278	1280	of
O	1281	1284	the
O	1285	1288	end
O	1289	1291	of
O	1292	1295	the
O	1296	1301	study
O	1301	1302	.

O	1303	1306	The
O	1307	1313	median
O	1314	1320	follow
O	1320	1321	-
O	1321	1323	up
O	1324	1330	period
O	1331	1334	for
O	1335	1347	participants
O	1348	1350	in
O	1351	1355	this
O	1356	1364	analysis
O	1365	1368	was
O	1369	1371	17
O	1371	1372	.
O	1372	1373	8
O	1374	1380	months
O	1380	1381	.

O	1382	1384	In
O	1385	1393	weighted
O	1394	1407	multivariable
O	1408	1416	logistic
O	1417	1427	regression
O	1428	1436	analyses
O	1436	1437	,
O	1438	1443	women
O	1444	1446	in
O	1447	1450	the
O	1451	1463	intervention
O	1464	1469	group
O	1470	1473	had
O	1474	1487	significantly
O	1488	1494	higher
O	1495	1499	odds
O	1500	1502	of
B-outcome	1503	1508	being
I-outcome	1509	1511	up
I-outcome	1512	1514	to
I-outcome	1515	1519	date
I-outcome	1520	1522	on
I-outcome	1523	1534	mammography
I-outcome	1535	1544	screening
O	1545	1547	at
O	1548	1551	the
O	1552	1555	end
O	1556	1558	of
O	1559	1562	the
O	1563	1569	follow
O	1569	1570	-
O	1570	1572	up
O	1573	1579	period
O	1580	1588	compared
O	1589	1591	to
O	1592	1597	women
O	1598	1600	in
O	1601	1604	the
O	1605	1612	control
O	1613	1618	group
O	1619	1620	(
O	1620	1624	odds
O	1625	1630	ratio
O	1631	1632	[
O	1632	1634	OR
O	1634	1635	]
O	1636	1637	2
O	1637	1638	.
O	1638	1640	26
O	1640	1641	,
O	1642	1644	95
O	1645	1646	%
O	1647	1657	confidence
O	1658	1666	interval
O	1667	1668	[
O	1668	1670	CI
O	1670	1671	]
O	1671	1672	1
O	1672	1673	.
O	1673	1675	59
O	1675	1676	-
O	1676	1677	3
O	1677	1678	.
O	1678	1680	22
O	1680	1681	)
O	1681	1682	.

O	1683	1686	The
O	1687	1693	effect
O	1694	1696	of
O	1697	1700	the
O	1701	1713	intervention
O	1714	1717	was
O	1718	1726	stronger
O	1727	1732	among
O	1733	1738	women
O	1739	1742	who
O	1743	1747	were
O	1748	1751	not
O	1752	1754	up
O	1755	1757	to
O	1758	1762	date
O	1763	1767	with
O	1768	1779	mammography
O	1780	1789	screening
O	1790	1792	at
O	1793	1803	enrollment
O	1804	1805	(
O	1805	1807	OR
O	1808	1809	3
O	1809	1810	.
O	1810	1812	63
O	1812	1813	,
O	1814	1816	95
O	1817	1818	%
O	1819	1821	CI
O	1822	1823	2
O	1823	1824	.
O	1824	1826	09
O	1826	1827	-
O	1827	1828	6
O	1828	1829	.
O	1829	1831	38
O	1831	1832	)
O	1832	1833	.

O	1834	1841	Patient
O	1842	1852	navigation
O	1853	1858	among
O	1859	1864	urban
O	1865	1872	African
O	1873	1881	American
O	1882	1890	Medicare
O	1891	1904	beneficiaries
O	1905	1914	increased
O	1915	1919	self
O	1919	1920	-
O	1920	1928	reported
O	1929	1940	mammography
O	1941	1952	utilization
O	1952	1953	.

O	1954	1957	The
O	1958	1965	results
O	1966	1973	suggest
O	1974	1978	that
O	1979	1986	patient
O	1987	1997	navigation
O	1998	2001	for
O	2002	2013	mammography
O	2014	2023	screening
O	2024	2030	should
O	2031	2036	focus
O	2037	2039	on
O	2040	2045	women
O	2046	2049	who
O	2050	2053	are
O	2054	2057	not
O	2058	2060	up
O	2061	2063	to
O	2064	2068	date
O	2069	2071	on
O	2072	2077	their
O	2078	2087	screening
O	2087	2088	.
